In December 2007, while pursuing their graduate degrees under the supervision of Professor Tejal Desai at the University of California, San Francisco,
the founders of Nano Precision Medical began their entrepreneurial journey by winning a series of business plan competitions. In 2009, the project
was awarded a Catalyst grant from the California Institute for Quantitative Biology (QB3), providing the first significant funding to translate the
original idea into a startup company. This funding enabled the hiring of Will Fischer, who later became the first employee of the company and continues
with us presently.
Business Plan Competition Accolades
First Place and Trade Show Winner
Hong Kong University of Science and Technology International Business Plan Competition (2009)
ASME Innovator Showcase (Summer 2008)
International MBA Jungle Business Plan Competition (Spring 2008)
UC Berkeley Business Plan Competition (Spring 2008)
UC Berkeley Nanoclub Technology Challenge (Fall 2007)
In 2011, Dr. Kayte Fischer and Dr. Adam Mendelsohn dedicated themselves full-time towards realizing Nano Precision Medical’s vision.
Dr. Lily Peng completed her M.D. and Ph.D. in 2012, and remains actively engaged with Nano Precision Medical in an advisory capacity.
After spending its early years within the QB3 incubator network, Nano Precision Medical moved into its own space in Emeryville, CA in August 2013.
This facility provides plenty of space between offices and the lab, an inspiring view of the San Francisco Bay and Bay Bridge, and a perfect environment
for Nano Precision Medical to grow as it continues making progress.
Based on the founders’ experience at the UC and its location in the heart of the San Francisco Bay Area, Nano Precision Medical
maintains a culture of creativity, energy, and integrity, while relentlessly advancing its technology and products. By combining
the flexibility and camaraderie of a tech startup with the precision and quality of a pharmaceutical company, Nano Precision Medical
has set its course to make a difference.